AR023876A1 - Composiciones para el tratamiento de afecciones esofagicas. - Google Patents
Composiciones para el tratamiento de afecciones esofagicas.Info
- Publication number
- AR023876A1 AR023876A1 ARP000102198A ARP000102198A AR023876A1 AR 023876 A1 AR023876 A1 AR 023876A1 AR P000102198 A ARP000102198 A AR P000102198A AR P000102198 A ARP000102198 A AR P000102198A AR 023876 A1 AR023876 A1 AR 023876A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- esofagic
- affections
- treatment
- gum
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 abstract 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 abstract 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 abstract 1
- 229920000926 Galactomannan Polymers 0.000 abstract 1
- 229920002581 Glucomannan Polymers 0.000 abstract 1
- 229940072056 alginate Drugs 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 239000000227 bioadhesive Substances 0.000 abstract 1
- 235000010418 carrageenan Nutrition 0.000 abstract 1
- 229920001525 carrageenan Polymers 0.000 abstract 1
- 229940113118 carrageenan Drugs 0.000 abstract 1
- 239000000679 carrageenan Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229940046240 glucomannan Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9910212.1A GB9910212D0 (en) | 1999-05-05 | 1999-05-05 | Improvements in or relating to organic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR023876A1 true AR023876A1 (es) | 2002-09-04 |
Family
ID=10852720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000102198A AR023876A1 (es) | 1999-05-05 | 2000-05-05 | Composiciones para el tratamiento de afecciones esofagicas. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6610667B1 (https=) |
| EP (2) | EP1614431B1 (https=) |
| JP (1) | JP2002544176A (https=) |
| CN (1) | CN1173743C (https=) |
| AR (1) | AR023876A1 (https=) |
| AT (2) | ATE417602T1 (https=) |
| AU (1) | AU774966B2 (https=) |
| BR (1) | BR0010209A (https=) |
| CA (1) | CA2371031C (https=) |
| DE (2) | DE60023873T2 (https=) |
| ES (1) | ES2251997T3 (https=) |
| GB (2) | GB9910212D0 (https=) |
| PL (1) | PL199445B1 (https=) |
| WO (1) | WO2000067799A1 (https=) |
| ZA (1) | ZA200109073B (https=) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2368013B (en) * | 2001-02-19 | 2004-07-28 | Richard Orlando Brown | An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain |
| GB2398496A (en) * | 2003-02-20 | 2004-08-25 | Reckitt Benckiser Healthcare | Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles |
| US20040185119A1 (en) * | 2003-02-26 | 2004-09-23 | Theuer Richard C. | Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency |
| ITRM20030154A1 (it) * | 2003-04-03 | 2004-10-04 | D M G Italia S R L | Sciroppo antireflusso. |
| CN1780880B (zh) * | 2003-04-25 | 2010-04-28 | 雷克特本克斯尔保健(英国)有限公司 | 可增稠的组合物 |
| WO2006085987A2 (en) | 2004-07-09 | 2006-08-17 | University Of Iowa Research Foundation | Rna interference in respiratory epitheial cells |
| FR2876581B1 (fr) * | 2004-10-20 | 2007-05-18 | Interpharm Dev | Composition bioadhesive a liberation programmee |
| JP4775807B2 (ja) * | 2004-12-02 | 2011-09-21 | 株式会社 メドレックス | 局所麻酔薬物含有ゼリー剤 |
| US8597709B2 (en) | 2005-04-12 | 2013-12-03 | Inovobiologic Inc. | Dietary supplement and methods of use |
| US8062686B2 (en) | 2005-04-12 | 2011-11-22 | InovoBiologics, Inc. | Dietary supplement, and methods of use |
| EP1931222B1 (en) * | 2005-10-05 | 2012-02-15 | FMC Biopolymer AS | Gelling compositions and methods |
| EP1859786A1 (en) * | 2006-05-16 | 2007-11-28 | Frutarom Netherlands B.V. | A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides |
| BRPI0704542B8 (pt) * | 2007-05-15 | 2021-05-25 | Univ Estadual Campinas Unicamp | composição farmacêutica, processo de obtenção da composição farmacêutica, uso de uma quantidade farmaceuticamente eficaz de anestésico e agente gelificante, produto e método de tratamento |
| AU2014262248B2 (en) * | 2007-07-30 | 2017-05-04 | Inovobiologic, Inc. | Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid |
| US8143314B1 (en) | 2007-09-13 | 2012-03-27 | Robert Carl Stover | Methods and formulations for treating ineffective or decreased esophageal motility |
| EP2214679B1 (en) * | 2007-11-13 | 2019-03-27 | Meritage Pharma, Inc. | Corticosteroid compositions |
| US20090148530A1 (en) * | 2007-12-08 | 2009-06-11 | Jamie Koufman | Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin |
| US20090145433A1 (en) * | 2007-12-08 | 2009-06-11 | Michael James | Apparatus for dispensing a powdered composition into the aerodigestive tract |
| PL2240018T3 (pl) * | 2008-01-04 | 2017-01-31 | Schabar Res Ass Llc | Kompozycja zawierająca środek przeciwbólowy i przeciwhistaminowy |
| AR070593A1 (es) * | 2008-02-08 | 2010-04-21 | Colgate Palmolive Co | Composiciones efervescentes |
| PL2296670T3 (pl) | 2008-05-13 | 2013-07-31 | Apharm Srl | Doustne zastosowanie glikozaminoglikanu i kompozycje |
| BRPI0912028A2 (pt) * | 2008-05-15 | 2015-10-06 | Firmenich & Cie | sistema de liberação para um ingrediente ativo. |
| WO2010108494A1 (en) * | 2009-03-25 | 2010-09-30 | S-Biotek Holding Aps | Dayspepsia treatment with alginate |
| EP2435021B1 (en) | 2009-05-25 | 2013-07-03 | Pharcoterm S.R.L. | Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination |
| TR201005241A1 (tr) * | 2010-05-25 | 2012-01-23 | Sanovel �La� San. Ve T�C. A.�. | Kontrollü salım sağlayan pregabalin solüsyon formülasyonu. |
| ITRM20120041A1 (it) | 2012-02-08 | 2013-08-09 | Dicofarm Spa | "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo" |
| US9452135B2 (en) | 2012-03-20 | 2016-09-27 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
| US9636360B2 (en) * | 2012-09-18 | 2017-05-02 | pH Science Holdings, Inc | Method and composition for treating gastro-esophageal disorders |
| IT201600088648A1 (it) * | 2016-08-31 | 2018-03-03 | Alpiflor S R L | Composizione nutrizionale o farmaceutica ed integratore alimentare contenente detta compsizione nutrizionale o farmaceutica |
| IT201600121601A1 (it) * | 2016-11-30 | 2018-05-30 | Nekkar Lab Srl | Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo |
| IT201600121617A1 (it) * | 2016-11-30 | 2018-05-30 | Nekkar Lab Srl | Composizione per il trattamento del reflusso gastroesofageo |
| CN106420773A (zh) * | 2016-12-21 | 2017-02-22 | 郑州莉迪亚医药科技有限公司 | 一种治疗放射性肠炎的中西药组合物及其制备方法和应用 |
| IT201700108526A1 (it) | 2017-09-28 | 2019-03-28 | Alfasigma Spa | Composizioni orali per il trattamento del refluso gastroesofageo. |
| IL312094A (en) * | 2018-03-02 | 2024-06-01 | Pharagen Llc | Formulations treating acid reflux comprising sodium alginate |
| WO2019172261A1 (ja) * | 2018-03-05 | 2019-09-12 | 国立大学法人東京大学 | 食道狭窄防止材料 |
| CN109432232B (zh) * | 2018-12-07 | 2021-11-26 | 纽湃腾（北京）医药科技有限公司 | 一种改善调节胃食管反流的海藻酸盐组合物及应用 |
| CN109432233A (zh) * | 2018-12-07 | 2019-03-08 | 纽湃腾（北京）医药科技有限公司 | 一种含有猴头菇提取物的抑反流护胃组合物及应用 |
| CN110840853A (zh) * | 2019-10-26 | 2020-02-28 | 张强 | 胃镜检查用咀嚼或含化型口咽部局麻药及服用方法 |
| US12514846B2 (en) | 2020-07-15 | 2026-01-06 | Schabar Research Associates Llc | Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach |
| CA3124579C (en) | 2020-07-15 | 2026-03-31 | Schabar Research Associates Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
| EP4181912A1 (en) | 2020-07-15 | 2023-05-24 | Schabar Research Associates LLC | Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn |
| IT202000031421A1 (it) * | 2020-12-18 | 2022-06-18 | Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L | Composizione multicomponente comprendente saccarosio solfato o suoi derivati per il trattamento del reflusso gastrico |
| PL4262824T3 (pl) * | 2020-12-18 | 2026-03-30 | Drugs Minerals And Generics Italia S.R.L. In Forma Abbreviata D.M.G. Italia S.R.L. | Wieloskładnikowa kompozycja zawierająca siarczan sacharozy, alginian i gumę gellanową do leczenia refluksu żołądkowego |
| IT202000031433A1 (it) * | 2020-12-18 | 2022-06-18 | Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L | Composizioni comprendenti saccarosio octasolfato per il trattamento del reflusso gastrico |
| IT202000031409A1 (it) * | 2020-12-18 | 2022-06-18 | Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L | Composizione multicomponente comprendente gomma gellano e suo uso per il trattamento del reflusso gastrico |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57133170A (en) * | 1981-02-12 | 1982-08-17 | Kikusui Kagaku Kogyo Kk | Thermochromic coating compound with colorful pattern |
| US4717713A (en) * | 1983-10-31 | 1988-01-05 | Research Corporation | Controlled release liquid pharmaceutical |
| US5169639A (en) * | 1988-09-19 | 1992-12-08 | Edward Mendell Co., Inc. | Controlled release verapamil tablets |
| GB8911177D0 (en) * | 1989-05-16 | 1989-07-05 | Vilain Jean | Alginate gel pharmaceutical product |
| PL170554B1 (pl) * | 1991-12-17 | 1996-12-31 | Fuisz Technologies Ltd | Sposób wytwarzania kompozycji przeciwwrzodowej PL PL PL |
| GB9322314D0 (en) * | 1993-10-29 | 1993-12-15 | Scherer Ltd R P | Foam generating capsules |
| GB9708773D0 (en) * | 1997-04-30 | 1997-06-25 | Reckitt & Colmann Prod Ltd | Organic compositions |
| US6030641A (en) * | 1997-06-03 | 2000-02-29 | Uni Colloid Kabushiki Kaisha | Sustained release capsule and method for preparing the same |
-
1999
- 1999-05-05 GB GBGB9910212.1A patent/GB9910212D0/en not_active Ceased
-
2000
- 2000-05-04 ES ES00927500T patent/ES2251997T3/es not_active Expired - Lifetime
- 2000-05-04 PL PL351134A patent/PL199445B1/pl unknown
- 2000-05-04 US US09/979,538 patent/US6610667B1/en not_active Expired - Fee Related
- 2000-05-04 CN CNB008069573A patent/CN1173743C/zh not_active Expired - Fee Related
- 2000-05-04 DE DE60023873T patent/DE60023873T2/de not_active Expired - Lifetime
- 2000-05-04 AU AU45900/00A patent/AU774966B2/en not_active Ceased
- 2000-05-04 AT AT05019522T patent/ATE417602T1/de not_active IP Right Cessation
- 2000-05-04 BR BR0010209-1A patent/BR0010209A/pt active Search and Examination
- 2000-05-04 EP EP05019522A patent/EP1614431B1/en not_active Expired - Lifetime
- 2000-05-04 GB GB0010669A patent/GB2349570B/en not_active Expired - Lifetime
- 2000-05-04 EP EP00927500A patent/EP1173218B1/en not_active Expired - Lifetime
- 2000-05-04 JP JP2000616824A patent/JP2002544176A/ja not_active Abandoned
- 2000-05-04 CA CA002371031A patent/CA2371031C/en not_active Expired - Fee Related
- 2000-05-04 WO PCT/GB2000/001711 patent/WO2000067799A1/en not_active Ceased
- 2000-05-04 AT AT00927500T patent/ATE308997T1/de not_active IP Right Cessation
- 2000-05-04 DE DE69940131T patent/DE69940131D1/de not_active Expired - Lifetime
- 2000-05-05 AR ARP000102198A patent/AR023876A1/es unknown
-
2001
- 2001-11-01 ZA ZA200109073A patent/ZA200109073B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2371031A1 (en) | 2000-11-16 |
| DE60023873T2 (de) | 2006-08-03 |
| AU4590000A (en) | 2000-11-21 |
| EP1614431A2 (en) | 2006-01-11 |
| ZA200109073B (en) | 2003-01-29 |
| EP1173218B1 (en) | 2005-11-09 |
| US6610667B1 (en) | 2003-08-26 |
| WO2000067799A1 (en) | 2000-11-16 |
| ATE417602T1 (de) | 2009-01-15 |
| CN1173743C (zh) | 2004-11-03 |
| GB0010669D0 (en) | 2000-06-28 |
| AU774966B2 (en) | 2004-07-15 |
| PL199445B1 (pl) | 2008-09-30 |
| GB2349570B (en) | 2002-05-22 |
| ES2251997T3 (es) | 2006-05-16 |
| DE69940131D1 (de) | 2009-01-29 |
| CA2371031C (en) | 2008-09-30 |
| DE60023873D1 (de) | 2005-12-15 |
| BR0010209A (pt) | 2002-02-19 |
| CN1349418A (zh) | 2002-05-15 |
| EP1614431B1 (en) | 2008-12-17 |
| EP1173218A1 (en) | 2002-01-23 |
| GB9910212D0 (en) | 1999-06-30 |
| GB2349570A (en) | 2000-11-08 |
| ATE308997T1 (de) | 2005-11-15 |
| JP2002544176A (ja) | 2002-12-24 |
| EP1614431A3 (en) | 2006-03-01 |
| PL351134A1 (en) | 2003-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR023876A1 (es) | Composiciones para el tratamiento de afecciones esofagicas. | |
| BR9917089A (pt) | Composições e métodos para distribuição mucosal | |
| BR0112962A (pt) | Composições farmacêuticas para o tratamento de condições inflamatórias e ulcerativas dolorosas de maioria das superfìcies epiteliais tais como mucosite, estomatite e sìndrome de behcet | |
| NO20002741L (no) | Vaksine-blandinger omfattende kitosan, for mukosal administrasjon | |
| NO971192D0 (no) | Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt | |
| IL154888A0 (en) | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid | |
| ES2181361T3 (es) | Composiciones medicinales. | |
| PL1898876T3 (pl) | Preparaty mukoadhezyjne zawierające ksyloglukan, użyteczne w wyrobach medycznych i preparatach farmaceutycznych | |
| AR027391A1 (es) | Composiciones farmaceuticas de toxina botulinica | |
| CO5160320A1 (es) | Metodos y composiciones para la prevencion de tolerancia a medicamentos das. | |
| BR9611802A (pt) | Composições farmacêuticas | |
| SE9300581L (sv) | Komposition för nasalbehandling | |
| PL375621A1 (pl) | Kompozycje farmaceutyczne zawierające flawonoidy i mentol | |
| BR0308206A (pt) | Composição oral sinergìstica com composto volátil de enxofre para o controle de odor para hálito, e, método para neutralizar sinergisticamente o odor de hálito de composto volátil de enxofre | |
| DK1121127T3 (da) | Orale farmaceutiske sammensætninger, som indeholder buprenorphin | |
| CY1108548T1 (el) | Βιοπροσκολλητικη γελη βασισμενη σε υδροξυαιθυλοκυτταρινη | |
| BRPI0212298B8 (pt) | composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico | |
| BR0110506A (pt) | Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose | |
| BR0010546A (pt) | Terapia antiinflamatória para infecção mediada inflamatória | |
| IL172180A (en) | Use of at least one herb extract from the genus equisetum and at least one film forming agent for the preparation of topical compositions for treating onychoschizia | |
| AR008797A1 (es) | Composicion. | |
| ATE268175T1 (de) | Decursin-enthaltende pharmazeutische zusammensetzungen | |
| YU39598A (sh) | Upotreba duloksetina i njegova farmaceutska smeša | |
| AR047480A1 (es) | Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion | |
| BR0213934A (pt) | Composições orais sólidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |